Search by CAS No , Chemical Name or Molecular Formula
"Cefuroxime is an enteral second-generation cephalosporin antibiotic. It was discovered by the Glaxo, now GlaxoSmithKline and first marketed in 1978 as Zinacef. It received approval from the U.S. Food and Drug Administration in October 1983.
Cefuroxime axetil is an acetoxyetyl-ester-prodrug of cefuroxime which is effective orally.",""
Impurity in commercial preparations of Cefuroxime.
Pichichero ME (2006); Gsk-india.com. 26 March 2013.
We normally respond within 8 hours.
This page contains information about Cefuroxime Sodium EP Impurity B Cas # NA and its Impurities.
Cefuroxime Sodium EP Impurity B Cefuroxime Sodium EP Impurity B Worldwide Suppliers of Cefuroxime Sodium EP Impurity B https://www.clearsynth.com/en/CSO10546.html Impurities Clearsynth NA
Product rating: 9 Cefuroxime Sodium EP Impurity B based on 20 ratings
Keywords: Impurities (6R,7R)-3--2-yl)(methoxyiminxo-5-thia-1-
azabcclo[4.2.0]ct-2-ene-2carboxylc cid CS-O-10546 Cefuroxime Sodium EP Impurity B Cefuroxime NA 423.4 C17H17N3O8S
Internal standard, Internal standard Cefuroxime, HPLC-MS method validation, HPLC-MS method validation Cefuroxime, LC-MS-MS method validation, LC-MS-MS method validation Cefuroxime, Deuterated internal standard, Deuterated internal standard Cefuroxime, Deuterated Cefuroxime, Deuterium labeled Cefuroxime, Quantitative bioanalytical methods, Quantitative bioanalytical methods Cefuroxime, Blood samples Cefuroxime, Blood concentrations, Heavy drugs, Analysis, Analysis Cefuroxime, Clinical diagnostic, Clinical diagnostic Cefuroxime, Dosing Cefuroxime, Analytical method development, Internal standard method.
CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060
CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
T : +91-40-27155481
CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
T : +91-22-45045945